New patent for Allergan Holdings drug VIBERZI

Annual Drug Patent Expirations for VIBERZI Viberzi is a drug marketed by Allergan Holdings and is included in one NDA. It is available from one supplier. There are nineteen patents…
The post New patent for Allergan Holdings drug VIBERZI appeared first …


New patent for Beigene drug BRUKINSA

Annual Drug Patent Expirations for BRUKINSA Brukinsa is a drug marketed by Beigene and is included in one NDA. There are four patents protecting this drug. This drug has forty-four…
The post New patent for Beigene drug BRUKINSA appeared first on DrugPa…


Get email updates

Get new actionable insights and updates from BiotechBlog

Biotechblog